| Application no. and date | 06813945.0 (espacenet) (Federated) (European Patent Register), 20060830 | | Patent/reg. no. and date | DK/EP 1933869, 20091014 | | Publication date | 20080625 | | Priority no. and date | US 713792 P, 20050901, US 837312 P, 20060811 | | EP pub. no. and date |
EP 1933869 20080625 | | Effective date | | | Applicant/owner | The Government Of The United States Of America
As Represented By The Secretary Of The Department
Of Health And Human Services, National Institutes of Health
Office of Technology Transfer
60011 Executive Boulevard
Suite 325
Rockville, MD 20852-3804, US,
Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rayway, New Jersey 07065, US | | Applicant ref. no. | 153463 | | Inventor | KASTELEIN, Robert, A., 463 Summit Drive
Redwood City, CA 94062, US,
TSAI, Van, T., 12892 Ralston Circle
San Diego, CA 92130, US,
CUA, Daniel, J., 17418 Bear Creek Road
Boulder Creek, CA 95006, US,
CASPI, Rachel, 4508 Avamere Street
Bethesda, MD 20814, US,
SILVER, Phyllis, 1921 Locust Grove Road
Silver Spring, MD 20910, US,
LUGER, Dror, 371 Congressional Lane
Rockville, MD 20852, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 27/00 (2006.01) | | Title | Anvendelse af IL-23- og IL-17-antagonister til behandling af autoimmun øjenbetændelsessygdom | | Int. application no. | US2006033840 | | Int. publication no. | WO2007027761 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
